BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2081093)

  • 1. Hepatic encephalopathy.
    Ventura E
    Ann Ital Med Int; 1990; 5(3 Pt 3):325-32. PubMed ID: 2081093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatic encephalopathy].
    Hilgard P; Gerken G
    Med Klin (Munich); 2004 Oct; 99(10):591-602. PubMed ID: 15490075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of hepatic encephalopathy].
    Egberts EH
    Leber Magen Darm; 1987 Aug; 17(4):244, 247-62, 265-73. PubMed ID: 3312884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic management of hepatic encephalopathy].
    Helewski KJ; Kowalczyk-Ziomek GI; Konecki JJ
    Wiad Lek; 2002; 55(5-6):301-9. PubMed ID: 12235697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatic encephalopathy in patients with cirrhosis: new aspects and practical recommendations].
    Ditisheim S; Spahr L
    Rev Med Suisse; 2010 Sep; 6(261):1667-71. PubMed ID: 20939401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of bacterial infections as precipating factors of chronic hepatic encephalopathy in cirrhosis.
    Strauss E; da Costa MF
    Hepatogastroenterology; 1998; 45(21):900-4. PubMed ID: 9684155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic encephalopathy: from pathophysiology to treatment.
    Mas A
    Digestion; 2006; 73 Suppl 1():86-93. PubMed ID: 16498256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic encephalopathy.
    Córdoba J; Mínguez B
    Semin Liver Dis; 2008 Feb; 28(1):70-80. PubMed ID: 18293278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal hepatic encephalopathy: time to recognise and treat.
    Dhiman RK; Chawla YK
    Trop Gastroenterol; 2008; 29(1):6-12. PubMed ID: 18564660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Portosystemic encephalopathy].
    Figueroa Barrios R
    Rev Gastroenterol Peru; 1991; 11(2):119-28. PubMed ID: 1820181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of hepatic encephalopathy in patients with cirrhosis.
    Wright G; Jalan R
    Best Pract Res Clin Gastroenterol; 2007; 21(1):95-110. PubMed ID: 17223499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of hepatic encephalopathy.
    Blei AT
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Dec; 14(6):959-74. PubMed ID: 11139349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathogenesis of cirrhotic hepatic encephalopathy. Treatment implications].
    García-Compean D; Michel H
    Rev Gastroenterol Mex; 1995; 60(3):159-68. PubMed ID: 7481451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and therapy of portosystemic encephalopathy].
    Weissenborn K
    Schweiz Rundsch Med Prax; 1994 Sep; 83(38):1059-64. PubMed ID: 7939069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: bacterial flora and pathogenesis in hepatic encephalopathy.
    Williams R
    Aliment Pharmacol Ther; 2007 Feb; 25 Suppl 1():17-22. PubMed ID: 17295848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of hepatic encephalopathy. Changes in the cerebrospinal fluid concentration of catecholamine neurotransmitters, ammonia and amino acids in the course of an infusion treatment with branched-chain amino acids].
    Rössle M; Herz R; Lehmann G; Luft M; Gerok W
    Infusionsther Klin Ernahr; 1982 Oct; 9(5):256-8. PubMed ID: 7141673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful balloon-occluded retrograde transvenous obliteration (B-RTO) in a case of symptomatic epilepsy with hepatic encephalopathy due to non-cirrhotic porto-systemic shunt].
    Shibata A; Hayashi S; Noguchi M
    Rinsho Shinkeigaku; 2005 May; 45(5):341-5. PubMed ID: 15960169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic encephalopathy.
    Mullen KD; Gacad R
    Gastroenterologist; 1996 Sep; 4(3):188-202. PubMed ID: 8891683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe recurrent hepatic encephalopathy that responded to oral branched chain amino acids.
    Chalasani N; Gitlin N
    Am J Gastroenterol; 1996 Jun; 91(6):1266-8. PubMed ID: 8651189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.